The company would like to grow through acquisitions of a pharmaceutical contract research organization which makes a drug development in phase 2 to 4 of clinical stage with more than $5M of EBITDA.
The buyer is a fully integrated biopharmaceutical solutions organization which consist of a contract research organization (CRO) and a contract commercial organization (CCO).
This business was originally created through the merger of two industry leading companies in the segment.
Company’s mission is to find the most effective ways to help clients navigate in increasingly complex marketplace.
Areas where the company operates: CRO, Clinical Trials, and Commercialization.
Contact us to get details about this company wanted.
Bringing new therapies to market such as translational sciences, early phase communications, deployment solutions and medication adherence.
Finding effective ways to help clients navigate in increasingly complex marketplace.
Feel free to contact us for more information regarding this generic drugs company wanted in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.